Paul Baldrick

Preclinical development of monoclonal antibodies

Kathryn Chapman, Nick Pullen, Lee Coney et al. · mAbs · 2009 · 95 citations · Full text

Immunology, Mab Development, Immunotherapy +17

Safety Evaluation of Monophosphoryl Lipid A (MPL): An Immunostimulatory Adjuvant

Paul Baldrick, Derek Richardson, Gary Elliott et al. · Regulatory Toxicology and Pharmacology · 2002 · 86 citations

Inflammation, Lipid Preparation, Medicine +5

The design of chronic toxicology studies of monoclonal antibodies: Implications for the reduction in use of non-human primates

Kathryn Chapman, Laura Andrews, Jeffrey J. Bajramović et al. · Regulatory Toxicology and Pharmacology · 2011 · 67 citations

Autoimmune Disease, Immunotoxicology, Medicine +12

Safety evaluation of phytosterol esters. Part 8. Lack of genotoxicity and subchronic toxicity with phytosterol oxides

Linda J. Lea, Paul Hepburn, Alison Wolfreys et al. · Food and Chemical Toxicology · 2004 · 61 citations

Phytosterol Esters, Biochemistry, Medicine +7

Safety evaluation of biological drugs: What are toxicology studies in primates telling us?

Paul Baldrick · Regulatory Toxicology and Pharmacology · 2010 · 46 citations

Drug Safety, Preclinical Drug Evaluation, Pharmacology +7